Circulating Tumor DNA Is Associated with Response and Survival in Patients with Advanced Leiomyosarcoma

PURPOSE: We sought to determine whether the detection of circulating tumor DNA (ctDNA) in samples of patients undergoing chemotherapy for advanced leiomyosarcoma (LMS) is associated with objective response or survival. EXPERIMENTAL DESIGN: Using ultra–low-passage whole-genome sequencing (ULP-WGS) of...

Descripción completa

Detalles Bibliográficos
Autores principales: Madanat-Harjuoja, Laura M., Klega, Kelly, Lu, Yao, Shulman, David S., Thorner, Aaron R., Nag, Anwesha, Tap, William D., Reinke, Denise K., Diller, Lisa, Ballman, Karla V., George, Suzanne, Crompton, Brian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359745/
https://www.ncbi.nlm.nih.gov/pubmed/35561344
http://dx.doi.org/10.1158/1078-0432.CCR-21-3951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359745/
https://www.ncbi.nlm.nih.gov/pubmed/35561344
http://dx.doi.org/10.1158/1078-0432.CCR-21-3951

Ejemplares similares